The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Genetic diversity and evolution of hepatitis C virus – 15 years on
Abstract
In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defences and the immune system. This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis. On one hand, diversification of HCV has been constrained by its intimate adaptation to its host. Despite the >30 % nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development. Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defence pathways; this series of highly complex virus–host interactions may represent key components in establishing its ‘ecological niche’ in the human liver. On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires. If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants. These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neutral Theory of Molecular Evolution
Kimura, M. (1979) · Scientific American · doi:10.1038/scientificamerican1179-98 · Cited by 7,666
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
The Neutral Theory of Molecular Evolution
Kimura, M. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511623486 · Cited by 6,347
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Drake, J. W., Charlesworth, B., Charlesworth, D., & Crow, J. F. (1998) · Genetics · doi:10.1093/genetics/148.4.1667 · Cited by 1,932
King, J. L., & Jukes, T. H. (1969) · Science · doi:10.1126/science.164.3881.788 · Cited by 1,768
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., et al. (1999) · Nature · doi:10.1038/17130 · Cited by 1,763
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Cited by
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Unravelling hepatitis C virus replication from genome to function
Lindenbach, B. D., & Rice, C. M. (2005) · Nature · doi:10.1038/nature04077 · Cited by 820
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Lu, L., Li, C., & Hagedorn, C. H. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.482 · Cited by 738
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
Webster, D. P., Klenerman, P., & Dusheiko, G. M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62401-6 · Cited by 439
Hepatitis C virus hijacks host lipid metabolism
Syed, G. H., Amako, Y., & Siddiqui, A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.07.005 · Cited by 363
Prospects for a vaccine against the hepatitis C virus
Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312
RNA Viruses: ROS-Mediated Cell Death
Reshi, M. L., Su, Y.-C., & Hong, J.-R. (2014) · International Journal of Cell Biology · doi:10.1155/2014/467452 · Cited by 305
Hepatitis C genotype 4: What we know and what we don't yet know†
Kamal, S. M., & Nasser, I. A. (2008) · Hepatology · doi:10.1002/hep.22127 · Cited by 301
Characterization of a canine homolog of hepatitis C virus
Kapoor, A., Simmonds, P., Gerold, G., Qaisar, N., Jain, K., Henriquez, J. A., Firth, C., Hirschberg, D. L., Rice, C. M., Shields, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101794108 · Cited by 288
Self-citationBats are a major natural reservoir for hepaciviruses and pegiviruses
Quan, P.-L., Firth, C., Conte, J. M., Williams, S. H., Zambrana-Torrelio, C. M., Anthony, S. J., Ellison, J. A., Gilbert, A. T., Kuzmin, I. V., Niezgoda, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303037110 · Cited by 285
Regulation of hepatic innate immunity by hepatitis C virus
Horner, S. M., & Gale, M. (2013) · Nature Medicine · doi:10.1038/nm.3253 · Cited by 278
Sofia, M. J., Chang, W., Furman, P. A., Mosley, R. T., & Ross, B. S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201384j · Cited by 275
Osburn, W. O., Snider, A. E., Wells, B. L., Latanich, R., Bailey, J. R., Thomas, D. L., Cox, A. L., & Ray, S. C. (2014) · Hepatology · doi:10.1002/hep.27013 · Cited by 272
Frequency and Dynamics of Recombination within Different Species of Human Enteroviruses
Simmonds, P., & Welch, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.483-493.2006 · Cited by 269
Self-citationHepatitis C virus NS3/4a protease inhibitors
McCauley, J. A., & Rudd, M. T. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.015 · Cited by 120
Convergent evolution of escape from hepaciviral antagonism in primates
Patel, M. R., Loo, Y.-M., Horner, S. M., Gale, M., & Malik, H. S. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001282 · Cited by 95
“HCV is a single-stranded positive sense RNA virus that belongs to the Flaviviridae class of viruses that causes chronic liver disease and is estimated to infect 170 million people globally (about 3% of the world’s population) [14,15].”
Background
Metadata
- Authors
- Simmonds, P.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2004-11-01
- Volume
- 85
- Issue
- 11
- Pages
- 3173-3188
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2122987848
- Cited by
- 865
- References
- 101
- FWCI
- 26.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.